https://www.marketscreener.com/quote/stock/OXURION-NV-29715/news/ThromboGenics-Achieves-Important-Milestone-in-the-Development-of-THR-149-A-Novel-Plasma-Kallikrei-24233493/?utm_source=telegram&utm_medium=social&utm_campaign=share